Fetal Growth Restriction: Management Using Two Guidelines - Fetal Growth Antenatal Management Evaluation

Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Jun 30, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how different guidelines for managing pregnancies affected by fetal growth restriction (FGR) can impact newborn outcomes. Specifically, it aims to compare two sets of guidelines: one from the Society of Maternal-Fetal Medicine and the other from the International Society of Ultrasound in Obstetrics and Gynecology. The researchers want to see how these guidelines affect various outcomes for babies, such as whether they need to go to the neonatal intensive care unit (NICU), and how often cesarean deliveries happen.

To participate in this study, pregnant individuals must have a diagnosis of FGR, which means their baby is not growing as expected based on ultrasound measurements. This typically includes babies with an estimated weight or abdominal size smaller than 10% of what is normal for their gestational age. Unfortunately, those expecting multiple babies (like twins or triplets) with FGR won’t be eligible. The trial is not yet recruiting participants, but when it begins, those who join can expect to be monitored closely according to the assigned guideline, helping to gather important information about the best ways to manage FGR in pregnancy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • FGR diagnosed during sonographic examinations
• • estimated fetal weight less than or a fetal abdominal circumference less than the 10th percentile
• Exclusion Criteria:
• • Multiple gestations with FGR